P152: Fatty liver disease in IBD patients as a part of extraintestinal manifestations
ECCO '19 Copenhagen
2019
P153: Quantum blue anti-adalimumab: development and evaluation of a point of care rapid test for measuring anti-adalimumab antibodies in human serum
ECCO '19 Copenhagen
2019
P154: Development of a novel ultrasound based score for assessing disease activity in ulcerative colitis: preliminary results
ECCO '19 Copenhagen
2019
P155: Adherence to quality indicators among patients with inflammatory bowel disease: an international comparative analysis
ECCO '19 Copenhagen
2019
P156: Long-term outcomes of steroid-responsive and non-responsive patients with acute severe ulcerative colitis
ECCO '19 Copenhagen
2019
P158: Comparison of three endoscopic scores for prediction of relapse risk in ulcerative colitis
ECCO '19 Copenhagen
2019
P159: The creatinine / cystatin C ratio is a surrogate marker of low skeletal muscle mass in patients with inflammatory bowel disease
ECCO '19 Copenhagen
2019
P160: Hypercoagulability in patients undergoing abdominopelvic surgery for inflammatory bowel disease: insights from thromboelastography
ECCO '19 Copenhagen
2019
P161: Faecal calprotectin identifies microscopic inflammation in ulcerative colitis patients with complete endoscopic healing: a post-hoc analysis of the MOMENTUM trial
ECCO '19 Copenhagen
2019
P162: RAID-Monitor: a new non-invasive method to determine endoscopic activity in inflammatory bowel diseases
ECCO '19 Copenhagen
2019
P163: Transmural healing assessed using MRI scores is associated with better outcomes and is a potential therapeutic target in patients with Crohn’s disease
ECCO '19 Copenhagen
2019
P165: A global prospective observational study in children and adolescents with paediatric-onset IBD: the PIBD-SETQuality inception cohort
ECCO '19 Copenhagen
2019
P166: A combined set of four serum inflammatory biomarkers reliably predicts endoscopic disease activity in inflammatory bowel disease
ECCO '19 Copenhagen
2019
P167: The variation of faecal calprotectin level within the first months after bowel resection is predictive of endoscopic postoperative recurrence in patients with Crohn’s disease
ECCO '19 Copenhagen
2019
P168: Adjusting serum ferritin concentrations to remove the effects of acute-phase response in patients with IBD and iron deficiency: is using C-reactive protein sufficient?
ECCO '19 Copenhagen
2019
P169: Bowel ultrasound is accurate in assessing disease extent and disease activity in ulcerative colitis
ECCO '19 Copenhagen
2019
P170: Diagnostic criteria for IBD subtype classification: a multi-centre validation cohort
ECCO '19 Copenhagen
2019